LICENSING AND COLLABORATION ARRANGEMENTS - Additional information (Details) ¥ in Millions, $ in Millions |
6 Months Ended | |||
|---|---|---|---|---|
|
Oct. 15, 2025
USD ($)
|
Oct. 15, 2025
CNY (¥)
|
Jun. 30, 2026
USD ($)
|
Jun. 30, 2025
USD ($)
|
|
| Collaboration Agreement With ABL Bio | ||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
| Cost sharing reimbursements | $ 5.1 | $ 3.4 | ||
| Everest Medicines Pte Ltd | Assignment And Assumption Agreement | ||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
| Reimbursement of upfront licensing payment for rights to develop VIS-101 in Asian Territories | $ 7.0 | |||
| AskGene | License Agreement | ||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
| Reimbursement of upfront licensing payment for rights to develop VIS-101 in Asian Territories | ¥ | ¥ 24 | |||
| Payments made to third parties | $ 7.0 | |||